Top compounds associated with response to DYNC1I1


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC -0.2 0.0003
mRNA Irinotecan gCSI pan-cancer AAC -0.2 0.0003
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA Epothilone B GDSC1000 pan-cancer AAC -0.13 0.0004
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA Vandetanib CCLE pan-cancer AAC -0.18 0.0004
mRNA PLX4720 CCLE pan-cancer AAC 0.17 0.0004
mRNA Gemcitabine gCSI pan-cancer AAC -0.21 0.0005
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA GW-2580 GDSC1000 pan-cancer AAC 0.12 0.0006
Download CSV